PAN-301-1 (SNS-301)

PAN-301-1 · Sensei Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PAN-301-1 (SNS-301), covering 2021-11-12 to 2021-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients [Phase 1]